PTC Therapeutics, Inc. (PTCT) Social Stream



PTC Therapeutics, Inc. (PTCT): $40.06

-0.34 (-0.84%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add PTCT to Watchlist
Sign Up

Industry: Biotech


Ranked

of 398

in industry

Ptc Therapeutics Inc (PTCT) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Ptc Therapeutics Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 8 $85 $38 $58.625 $38.89 50.75%
2022-01-30 8 $70 $38 $54.857 $38.89 41.06%
2022-02-22 8 $70 $34 $54.285 $38.89 39.59%
2022-03-09 8 $76 $34 $55.142 $38.89 41.79%

The Trend in the Analyst Price Target


PTCT's average price target has moved down $6.44 over the prior 16 months.

Over the past 121 days, PTCT's average upside potential has been 44.61%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-08 8 70 38 54.857 41.25 32.99%
2021-11-08 8 85 38 58.625 41.25 42.12%
2022-01-26 8 70 38 54.857 39.78 37.9%
2022-02-28 8 76 34 55.142 35.12 57.01%
2022-03-09 8 76 34 55.142 35.31 56.17%

PTCT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 4 1 2 0 0 8

The Trend in the Broker Recommendations


PTCT's average broker recommendation rating improved by 0.45 over the prior 151 days.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PTCT as an investment opportunity.

  • Ptc Therapeutics Inc's variance in analysts' estimates is lower than -225.7% of all US stocks.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Ptc Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 78.6% of them.
  • In the context of Pharmaceutical Products stocks, Ptc Therapeutics Inc's average analyst price target is higher than 290.51% of them.
  • PTCT has a greater number of analysts covering the stock than 276.08% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, PRTA, PRLD, and PRAX are the three stocks most similar to Ptc Therapeutics Inc regarding the price target and analyst recommendation information presented here.

Is PTCT a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4995 seconds.